ArticleThe pharmacogenomics journal2025

Integrating epidemiology and genomics data to estimate the prevalence of acquired cysteine drug targets in the U.S. cancer patient population.

Adith S Arun et al.PubMed ↗Publisher ↗

No numbers read from the abstract.